90 related articles for article (PubMed ID: 20868595)
1. [Analysis of first-line chemoresistance and prediction of chemo-response in non-small cell lung cancer by comparative genomic hybridization].
Hu Y; Gao YN; Feng FY; Lin DM; Jiao SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):389-93. PubMed ID: 20868595
[TBL] [Abstract][Full Text] [Related]
2. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
3. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
4. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization.
Uchida K; Oga A; Okafuji M; Mihara M; Kawauchi S; Furuya T; Chochi Y; Ueyama Y; Sasaki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):109-16. PubMed ID: 16737909
[TBL] [Abstract][Full Text] [Related]
6. [Analyzing chromosomal abnormality in primary esophageal cancer by comparative genomic hybridization].
Wu SS; Liu JF; Wang MR
Ai Zheng; 2007 Feb; 26(2):132-6. PubMed ID: 17298740
[TBL] [Abstract][Full Text] [Related]
7. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.
Tai AL; Yan WS; Fang Y; Xie D; Sham JS; Guan XY
Cancer; 2004 May; 100(9):1918-27. PubMed ID: 15112273
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations in Korean nonsmall cell lung carcinomas: degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies.
Park SY; Kim YH; In KH; Chun YH; Park SH
Cancer Genet Cytogenet; 2004 Jul; 152(2):153-7. PubMed ID: 15262437
[TBL] [Abstract][Full Text] [Related]
9. p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
Vogt U; Zaczek A; Klinke F; Granetzny A; Bielawski K; Falkiewicz B
J Cancer Res Clin Oncol; 2002 Mar; 128(3):141-7. PubMed ID: 11935300
[TBL] [Abstract][Full Text] [Related]
10. Establishment and molecular cytogenetic characterization of non-small cell lung cancer cell line KU-T1 by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and chromosome microdissection.
Kume M; Taguchi T; Okada H; Anayama T; Tominaga A; Shuin T; Sasaguri S
Cancer Genet Cytogenet; 2007 Dec; 179(2):93-101. PubMed ID: 18036395
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer.
Li F; Sun X; Sun N; Qin S; Cheng H; Feng J; Chen B; Cheng L; Lu Z; Ji J; Zhou Y
Am J Clin Oncol; 2010 Oct; 33(5):489-94. PubMed ID: 20351547
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization analysis of a pleuropulmonary blastoma.
Roque L; Rodrigues R; Martins C; Ribeiro C; Ribeiro MJ; Martins AG; Oliveira P; Fonseca I
Cancer Genet Cytogenet; 2004 Feb; 149(1):58-62. PubMed ID: 15104284
[TBL] [Abstract][Full Text] [Related]
14. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
[TBL] [Abstract][Full Text] [Related]
15. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
16. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
[TBL] [Abstract][Full Text] [Related]
18. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
Van Dekken H; Krijtenburg PJ; Alers JC
Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
[TBL] [Abstract][Full Text] [Related]
19. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI
PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers.
Kim TM; Yim SH; Lee JS; Kwon MS; Ryu JW; Kang HM; Fiegler H; Carter NP; Chung YJ
Clin Cancer Res; 2005 Dec; 11(23):8235-42. PubMed ID: 16322280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]